What is the P/E ratio of Agenus 2025?
The Agenus P/E ratio is -0.37.
Access the world's leading financial data and tools
Subscribe for $2 
Overview
Profile
Agenus stock stock price, forecast, news, chart, split, dividend and analysis Agenus ariva, Agenus onvista, Agenus finanzen.net, Agenus aktienfinder, Agenus marketscreener, Agenus marketwatch, Agenus bloomberg, Agenus handelsblatt, Agenus wiwo, Agenus forum
AGEN
US00847G8042
A1JLKZ
Price
Price
3.54
Today +/-
-0.07
Today %
-1.96 %
TickerAGEN
ISINUS00847G8042
WKNA1JLKZ
Agenus stock price
%
Weekly
Details
Price
ⓘOverview
The Quote Chart provides detailed and dynamic insights into the Agenus stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.
Intraday Feature
The intraday feature provides real-time data, allowing investors to view the Agenus stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.
Total Return and Relative Price Change
View the total return of the Agenus stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.
Interpretation and Investment
Utilize the comprehensive data presented in the Quote Chart to analyze Agenus's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.
Agenus Stock Price History
| Date | Agenus Price |
|---|---|
| 1/30/2025 | 3.54 undefined |
| 1/29/2025 | 3.61 undefined |
| 1/28/2025 | 3.56 undefined |
| 1/27/2025 | 3.60 undefined |
| 1/24/2025 | 3.57 undefined |
| 1/23/2025 | 3.76 undefined |
| 1/22/2025 | 3.66 undefined |
| 1/21/2025 | 3.83 undefined |
| 1/17/2025 | 3.48 undefined |
| 1/16/2025 | 3.15 undefined |
| 1/15/2025 | 3.17 undefined |
| 1/14/2025 | 3.15 undefined |
| 1/13/2025 | 3.16 undefined |
| 1/10/2025 | 3.12 undefined |
| 1/8/2025 | 3.40 undefined |
| 1/7/2025 | 3.55 undefined |
| 1/6/2025 | 3.31 undefined |
| 1/3/2025 | 3.27 undefined |
| 1/2/2025 | 3.09 undefined |
Agenus Revenue, EBIT, Net Income US00847G8042 · A1JLKZ
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Agenus, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Agenus from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Agenus’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Agenus. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Agenus’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Agenus’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Agenus’s growth potential.
Agenus Revenue, EBIT and net profit per share
| Date | Agenus Revenue | Agenus EBIT | Agenus Net Income |
|---|---|---|---|
| 2030e | 386.24 M undefined | 0 undefined | -18.11 M undefined |
| 2029e | 292.16 M undefined | 20.13 M undefined | -55.44 M undefined |
| 2028e | 206.58 M undefined | -88.37 M undefined | -126.27 M undefined |
| 2027e | 126.43 M undefined | -155.17 M undefined | -201.91 M undefined |
| 2026e | 132.68 M undefined | -135.77 M undefined | -145.01 M undefined |
| 2025e | 150.15 M undefined | -93.51 M undefined | -172.1 M undefined |
| 2024e | 110.3 M undefined | -139.08 M undefined | -290.98 M undefined |
| 2023 | 156.31 M undefined | -160.11 M undefined | -245.97 M undefined |
| 2022 | 98.02 M undefined | -180.24 M undefined | -220.29 M undefined |
| 2021 | 295.67 M undefined | 37.23 M undefined | -24.14 M undefined |
| 2020 | 88.17 M undefined | -116.01 M undefined | -181.12 M undefined |
| 2019 | 150.05 M undefined | -70.14 M undefined | -107.87 M undefined |
| 2018 | 36.78 M undefined | -123.82 M undefined | -159.9 M undefined |
| 2017 | 42.88 M undefined | -103.8 M undefined | -120.9 M undefined |
| 2016 | 22.57 M undefined | -107.48 M undefined | -127.2 M undefined |
| 2015 | 24.82 M undefined | -80.7 M undefined | -88.08 M undefined |
| 2014 | 6.98 M undefined | -43.32 M undefined | -42.69 M undefined |
| 2013 | 3.05 M undefined | -24.98 M undefined | -33.23 M undefined |
| 2012 | 15.96 M undefined | -6.74 M undefined | -12.12 M undefined |
| 2011 | 2.76 M undefined | -19.09 M undefined | -24.07 M undefined |
| 2010 | 3.36 M undefined | -21.75 M undefined | -22.7 M undefined |
| 2009 | 3.33 M undefined | -27.68 M undefined | -31.11 M undefined |
| 2008 | 2.65 M undefined | -37.84 M undefined | -31.59 M undefined |
| 2007 | 5.55 M undefined | -33.28 M undefined | -38.73 M undefined |
| 2006 | 692,000 undefined | -49.24 M undefined | -52.67 M undefined |
| 2005 | 630,000 undefined | -72.32 M undefined | -74.89 M undefined |
| 2004 | 707,000 undefined | -66.8 M undefined | -56.95 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 707,000 USD | -66.8 M USD | -56.95 M USD |
| 2005 | 630,000 USD | -72.32 M USD | -74.89 M USD |
| 2006 | 692,000 USD | -49.24 M USD | -52.67 M USD |
| 2007 | 5.55 M USD | -33.28 M USD | -38.73 M USD |
| 2008 | 2.65 M USD | -37.84 M USD | -31.59 M USD |
| 2009 | 3.33 M USD | -27.68 M USD | -31.11 M USD |
| 2010 | 3.36 M USD | -21.75 M USD | -22.7 M USD |
| 2011 | 2.76 M USD | -19.09 M USD | -24.07 M USD |
| 2012 | 15.96 M USD | -6.74 M USD | -12.12 M USD |
| 2013 | 3.05 M USD | -24.98 M USD | -33.23 M USD |
| 2014 | 6.98 M USD | -43.32 M USD | -42.69 M USD |
| 2015 | 24.82 M USD | -80.7 M USD | -88.08 M USD |
| 2016 | 22.57 M USD | -107.48 M USD | -127.2 M USD |
| 2017 | 42.88 M USD | -103.8 M USD | -120.9 M USD |
| 2018 | 36.78 M USD | -123.82 M USD | -159.9 M USD |
| 2019 | 150.05 M USD | -70.14 M USD | -107.87 M USD |
| 2020 | 88.17 M USD | -116.01 M USD | -181.12 M USD |
| 2021 | 295.67 M USD | 37.23 M USD | -24.14 M USD |
| 2022 | 98.02 M USD | -180.24 M USD | -220.29 M USD |
| 2023 | 156.31 M USD | -160.11 M USD | -245.97 M USD |
| 2024e | 110.3 M USD | -139.08 M USD | -290.98 M USD |
| 2025e | 150.15 M USD | -93.51 M USD | -172.1 M USD |
| 2026e | 132.68 M USD | -135.77 M USD | -145.01 M USD |
| 2027e | 126.43 M USD | -155.17 M USD | -201.91 M USD |
| 2028e | 206.58 M USD | -88.37 M USD | -126.27 M USD |
| 2029e | 292.16 M USD | 20.13 M USD | -55.44 M USD |
| 2030e | 386.24 M USD | 0 USD | -18.11 M USD |
Agenus Income Statement, Balance Sheet, Cash Flow Statement
Simple
Expanded
Income Statement
Balance Sheet
Cashflow
| 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 4 | 3 | 0 | 0 | 0 | 0 | 5 | 2 | 3 | 3 | 2 | 15 | 3 | 6 | 24 | 22 | 42 | 36 | 150 | 88 | 295 | 98 | 156 | 110 | 150 | 132 | 126 | 206 | 292 | 386 |
| - | - | - | - | - | - | - | -25.00 | - | - | - | - | - | -60.00 | 50.00 | - | -33.33 | 650.00 | -80.00 | 100.00 | 300.00 | -8.33 | 90.91 | -14.29 | 316.67 | -41.33 | 235.23 | -66.78 | 59.18 | -29.49 | 36.36 | -12.00 | -4.55 | 63.49 | 41.75 | 32.19 |
| - | - | - | - | - | - | 75.00 | 66.67 | - | - | - | - | 3,060.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 66.67 | 100.00 | 100.00 | 695.45 | 364.29 | 425.00 | 102.00 | 96.59 | 98.98 | 88.78 | 98.08 | 139.09 | 102.00 | 115.91 | 121.43 | 74.27 | 52.40 | 39.64 |
| 0 | 0 | 0 | 0 | 0 | 0 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 3 | 2 | 15 | 2 | 6 | 24 | 0 | 0 | 0 | 0 | 85 | 292 | 87 | 153 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -3 | -3 | -3 | -8 | -18 | -46 | -73 | -55 | -66 | -56 | -74 | -52 | -38 | -31 | -31 | -22 | -24 | -12 | -33 | -42 | -88 | -127 | -120 | -159 | -107 | -181 | -24 | -220 | -245 | -290 | -172 | -145 | -201 | -126 | -55 | -18 |
| - | - | - | 166.67 | 125.00 | 155.56 | 58.70 | -24.66 | 20.00 | -15.15 | 32.14 | -29.73 | -26.92 | -18.42 | - | -29.03 | 9.09 | -50.00 | 175.00 | 27.27 | 109.52 | 44.32 | -5.51 | 32.50 | -32.70 | 69.16 | -86.74 | 816.67 | 11.36 | 18.37 | -40.69 | -15.70 | 38.62 | -37.31 | -56.35 | -67.27 |
| 0.11 | 0.12 | 0.13 | 0.14 | 0.15 | 0.21 | 0.24 | 0.27 | 0.33 | 0.37 | 0.38 | 0.38 | 0.39 | 0.53 | 0.66 | 0.81 | 1 | 1.18 | 1.49 | 2.99 | 3.91 | 4.35 | 4.92 | 5.54 | 6.75 | 8.63 | 11.45 | 14.09 | 17.89 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Details
Keystats
ⓘRevenue and Growth
The Agenus Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Agenus is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
Agenus stock margins US00847G8042 · A1JLKZ
The Agenus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Agenus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Agenus.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Agenus's sales revenue. A higher gross margin percentage indicates that the Agenus retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Agenus's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Agenus's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Agenus's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Agenus. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Agenus's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Agenus Margin History
| Agenus Gross margin | Agenus Profit margin | Agenus EBIT margin | Agenus Profit margin |
|---|---|---|---|
| 2030e | 98.01 % | 0 % | -4.69 % |
| 2029e | 98.01 % | 6.89 % | -18.97 % |
| 2028e | 98.01 % | -42.78 % | -61.12 % |
| 2027e | 98.01 % | -122.73 % | -159.7 % |
| 2026e | 98.01 % | -102.33 % | -109.29 % |
| 2025e | 98.01 % | -62.28 % | -114.62 % |
| 2024e | 98.01 % | -126.09 % | -263.81 % |
| 2023 | 98.01 % | -102.43 % | -157.36 % |
| 2022 | 89.22 % | -183.88 % | -224.73 % |
| 2021 | 98.83 % | 12.59 % | -8.16 % |
| 2020 | 97.34 % | -131.58 % | -205.42 % |
| 2019 | 98.01 % | -46.74 % | -71.89 % |
| 2018 | 98.01 % | -336.62 % | -434.7 % |
| 2017 | 98.01 % | -242.09 % | -281.96 % |
| 2016 | 98.01 % | -476.13 % | -563.5 % |
| 2015 | 100 % | -325.18 % | -354.93 % |
| 2014 | 100 % | -620.91 % | -611.87 % |
| 2013 | 82.4 % | -820.36 % | -1,091.36 % |
| 2012 | 95.79 % | -42.23 % | -75.92 % |
| 2011 | 100 % | -692.56 % | -873.26 % |
| 2010 | 96.34 % | -647.41 % | -675.51 % |
| 2009 | 100 % | -830.2 % | -933.05 % |
| 2008 | 100 % | -1,427.54 % | -1,191.66 % |
| 2007 | 98.01 % | -599.39 % | -697.5 % |
| 2006 | 100 % | -7,115.61 % | -7,611.71 % |
| 2005 | 100 % | -11,479.21 % | -11,887.94 % |
| 2004 | 99.29 % | -9,448.37 % | -8,055.45 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 99.29 % | -9,448.37 % | -8,055.45 % |
| 2005 | 100 % | -11,479.21 % | -11,887.94 % |
| 2006 | 100 % | -7,115.61 % | -7,611.71 % |
| 2007 | 98.01 % | -599.39 % | -697.5 % |
| 2008 | 100 % | -1,427.54 % | -1,191.66 % |
| 2009 | 100 % | -830.2 % | -933.05 % |
| 2010 | 96.34 % | -647.41 % | -675.51 % |
| 2011 | 100 % | -692.56 % | -873.26 % |
| 2012 | 95.79 % | -42.23 % | -75.92 % |
| 2013 | 82.4 % | -820.36 % | -1,091.36 % |
| 2014 | 100 % | -620.91 % | -611.87 % |
| 2015 | 100 % | -325.18 % | -354.93 % |
| 2016 | 98.01 % | -476.13 % | -563.5 % |
| 2017 | 98.01 % | -242.09 % | -281.96 % |
| 2018 | 98.01 % | -336.62 % | -434.7 % |
| 2019 | 98.01 % | -46.74 % | -71.89 % |
| 2020 | 97.34 % | -131.58 % | -205.42 % |
| 2021 | 98.83 % | 12.59 % | -8.16 % |
| 2022 | 89.22 % | -183.88 % | -224.73 % |
| 2023 | 98.01 % | -102.43 % | -157.36 % |
| 2024e | 98.01 % | -126.09 % | -263.81 % |
| 2025e | 98.01 % | -62.28 % | -114.62 % |
| 2026e | 98.01 % | -102.33 % | -109.29 % |
| 2027e | 98.01 % | -122.73 % | -159.7 % |
| 2028e | 98.01 % | -42.78 % | -61.12 % |
| 2029e | 98.01 % | 6.89 % | -18.97 % |
| 2030e | 98.01 % | 0 % | -4.69 % |
Agenus Stock Sales Revenue, EBIT, Earnings per Share US00847G8042 · A1JLKZ
The Agenus earnings per share therefore indicates how much revenue Agenus has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
3 years
5 years
10 years
25 Years
Max
Sales per Share
EBIT per share
Earnings per Share
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Agenus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Agenus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Agenus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Agenus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
Agenus Revenue, EBIT and net profit per share
| Date | Agenus Sales per Share | Agenus EBIT per share | Agenus Earnings per Share |
|---|---|---|---|
| 2030e | 16.46 undefined | 0 undefined | -0.77 undefined |
| 2029e | 12.45 undefined | 0 undefined | -2.36 undefined |
| 2028e | 8.81 undefined | 0 undefined | -5.38 undefined |
| 2027e | 5.39 undefined | 0 undefined | -8.61 undefined |
| 2026e | 5.66 undefined | 0 undefined | -6.18 undefined |
| 2025e | 6.4 undefined | 0 undefined | -7.34 undefined |
| 2024e | 4.7 undefined | 0 undefined | -12.4 undefined |
| 2023 | 8.74 undefined | -8.95 undefined | -13.75 undefined |
| 2022 | 6.96 undefined | -12.79 undefined | -15.64 undefined |
| 2021 | 25.83 undefined | 3.25 undefined | -2.11 undefined |
| 2020 | 10.22 undefined | -13.45 undefined | -21 undefined |
| 2019 | 22.23 undefined | -10.39 undefined | -15.98 undefined |
| 2018 | 6.64 undefined | -22.35 undefined | -28.87 undefined |
| 2017 | 8.71 undefined | -21.09 undefined | -24.57 undefined |
| 2016 | 5.18 undefined | -24.68 undefined | -29.21 undefined |
| 2015 | 6.35 undefined | -20.63 undefined | -22.52 undefined |
| 2014 | 2.34 undefined | -14.5 undefined | -14.29 undefined |
| 2013 | 2.05 undefined | -16.79 undefined | -22.33 undefined |
| 2012 | 13.51 undefined | -5.71 undefined | -10.26 undefined |
| 2011 | 2.77 undefined | -19.18 undefined | -24.19 undefined |
| 2010 | 4.17 undefined | -27.02 undefined | -28.2 undefined |
| 2009 | 5.07 undefined | -42.07 undefined | -47.28 undefined |
| 2008 | 5.03 undefined | -71.81 undefined | -59.94 undefined |
| 2007 | 14.31 undefined | -85.77 undefined | -99.81 undefined |
| 2006 | 1.81 undefined | -128.9 undefined | -137.89 undefined |
| 2005 | 1.66 undefined | -190.31 undefined | -197.09 undefined |
| 2004 | 1.9 undefined | -179.57 undefined | -153.1 undefined |
| Sales per Share | EBIT per share | Earnings per Share | |
|---|---|---|---|
| 2004 | 1.9 USD | -179.57 USD | -153.1 USD |
| 2005 | 1.66 USD | -190.31 USD | -197.09 USD |
| 2006 | 1.81 USD | -128.9 USD | -137.89 USD |
| 2007 | 14.31 USD | -85.77 USD | -99.81 USD |
| 2008 | 5.03 USD | -71.81 USD | -59.94 USD |
| 2009 | 5.07 USD | -42.07 USD | -47.28 USD |
| 2010 | 4.17 USD | -27.02 USD | -28.2 USD |
| 2011 | 2.77 USD | -19.18 USD | -24.19 USD |
| 2012 | 13.51 USD | -5.71 USD | -10.26 USD |
| 2013 | 2.05 USD | -16.79 USD | -22.33 USD |
| 2014 | 2.34 USD | -14.5 USD | -14.29 USD |
| 2015 | 6.35 USD | -20.63 USD | -22.52 USD |
| 2016 | 5.18 USD | -24.68 USD | -29.21 USD |
| 2017 | 8.71 USD | -21.09 USD | -24.57 USD |
| 2018 | 6.64 USD | -22.35 USD | -28.87 USD |
| 2019 | 22.23 USD | -10.39 USD | -15.98 USD |
| 2020 | 10.22 USD | -13.45 USD | -21 USD |
| 2021 | 25.83 USD | 3.25 USD | -2.11 USD |
| 2022 | 6.96 USD | -12.79 USD | -15.64 USD |
| 2023 | 8.74 USD | -8.95 USD | -13.75 USD |
| 2024e | 4.7 USD | 0 USD | -12.4 USD |
| 2025e | 6.4 USD | 0 USD | -7.34 USD |
| 2026e | 5.66 USD | 0 USD | -6.18 USD |
| 2027e | 5.39 USD | 0 USD | -8.61 USD |
| 2028e | 8.81 USD | 0 USD | -5.38 USD |
| 2029e | 12.45 USD | 0 USD | -2.36 USD |
| 2030e | 16.46 USD | 0 USD | -0.77 USD |
Agenus business model
Agenus is one of the most popular companies on Eulerpool.com.
Agenus Revenue by Segment US00847G8042 · A1JLKZ
3 years
5 years
Max
Details
Revenue by Segment
ⓘOverview of Revenue by Segment
The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.
Interpretation and Use
The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.
Investment Strategy
An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.
Agenus Revenue by Segment
| Segmente | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Research and development revenue | - | 120.7 M USD | 98.4 M USD | 99.85 M USD | 19.47 M USD |
| Research and Development Revenue | 130.3 M USD | - | - | - | - |
| Non cash royalty revenue related to the sale of future royalties and milestone | - | 44.36 M USD | 47.55 M USD | 30.42 M USD | - |
| Non-Cash Royalty Revenue Related to the Sale of Future Royalties and Milestones | 45.29 M USD | - | - | - | - |
| Royalty Sales Milestone | 25.3 M USD | - | - | - | - |
| Non cash royalty revenue related to the sale of future royalties | - | - | - | - | 17.31 M USD |
| Royalty sales milestone | - | - | - | 15.1 M USD | - |
| Revenue member | - | 6.7 M USD | 4.62 M USD | - | - |
| Other Revenues | - | 184,000 USD | 91,000 USD | 4.68 M USD | - |
| Service Revenue | 171,000 USD | - | - | - | - |
| Research and development revenue | Research and Development Revenue | Non cash royalty revenue related to the sale of future royalties and milestone | Non-Cash Royalty Revenue Related to the Sale of Future Royalties and Milestones | Royalty Sales Milestone | Non cash royalty revenue related to the sale of future royalties | Royalty sales milestone | Revenue member | Other Revenues | Service Revenue | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | 19.47 M USD | 0 USD | 0 USD | 0 USD | 0 USD | 17.31 M USD | 0 USD | 0 USD | 0 USD | 0 USD |
| 2019 | 99.85 M USD | 0 USD | 30.42 M USD | 0 USD | 0 USD | 0 USD | 15.1 M USD | 0 USD | 4.68 M USD | 0 USD |
| 2020 | 98.4 M USD | 0 USD | 47.55 M USD | 0 USD | 0 USD | 0 USD | 0 USD | 4.62 M USD | 91,000 USD | 0 USD |
| 2021 | 120.7 M USD | 0 USD | 44.36 M USD | 0 USD | 0 USD | 0 USD | 0 USD | 6.7 M USD | 184,000 USD | 0 USD |
| 2022 | 0 USD | 130.3 M USD | 0 USD | 45.29 M USD | 25.3 M USD | 0 USD | 0 USD | 0 USD | 0 USD | 171,000 USD |
3 years
5 years
Max
Details
Revenue by Segment
ⓘOverview of Revenue by Segment
The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.
Interpretation and Use
The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.
Investment Strategy
An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.
Agenus Revenue by Segment
| Segmente | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| License and Collaboration Revenue | - | - | - | 86.1 M USD | - |
| Upfront License Fee | - | - | - | 75.5 M USD | - |
| Research and development services | 1.68 M USD | 1.48 M USD | 754,000 USD | 1.71 M USD | - |
| License and Collaboration Revenue | Upfront License Fee | Research and development services | |
|---|---|---|---|
| 2018 | 0 USD | 0 USD | 0 USD |
| 2019 | 86.1 M USD | 75.5 M USD | 1.71 M USD |
| 2020 | 0 USD | 0 USD | 754,000 USD |
| 2021 | 0 USD | 0 USD | 1.48 M USD |
| 2022 | 0 USD | 0 USD | 1.68 M USD |
3 years
5 years
Max
Details
Revenue by Segment
ⓘOverview of Revenue by Segment
The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.
Interpretation and Use
The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.
Investment Strategy
An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.
Agenus Revenue by Segment
| Segmente | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| License and collaboration milestones | - | 220 M USD | - | - | - |
| Non cash royalty revenue related to the sale of future royalties | - | - | 47.55 M USD | 30.42 M USD | - |
| Recognition of deferred research and development revenue | - | 22.36 M USD | 12.3 M USD | 22.64 M USD | - |
| Non-cash royalty revenue | 45.29 M USD | - | - | - | - |
| License and Collaboration Revenue | - | - | - | - | 23 M USD |
| License fee revenue | - | - | 22.86 M USD | - | - |
| Other | - | 6.7 M USD | 4.62 M USD | - | - |
| Other services | 10.51 M USD | - | - | - | - |
| Recognition of Deferred Research and Development Revenue | 9.54 M USD | - | - | - | - |
| License Fee Revenue | 5 M USD | - | - | - | - |
| Research and development services | - | - | - | - | 4.15 M USD |
| Manufacturing services | - | - | - | 3.34 M USD | - |
| Recognition of Deferred Grant Revenue | - | 184,000 USD | 91,000 USD | 1.34 M USD | - |
| Clinical Product Revenue | 762,000 USD | - | - | - | - |
| Clinical product revenue | - | 587,000 USD | - | - | - |
| License and collaboration milestones | Non cash royalty revenue related to the sale of future royalties | Recognition of deferred research and development revenue | Non-cash royalty revenue | License and Collaboration Revenue | License fee revenue | Other | Other services | Recognition of Deferred Research and Development Revenue | License Fee Revenue | Research and development services | Manufacturing services | Recognition of Deferred Grant Revenue | Clinical Product Revenue | Clinical product revenue | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | 0 USD | 0 USD | 0 USD | 0 USD | 23 M USD | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD | 4.15 M USD | 0 USD | 0 USD | 0 USD | 0 USD |
| 2019 | 0 USD | 30.42 M USD | 22.64 M USD | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD | 3.34 M USD | 1.34 M USD | 0 USD | 0 USD |
| 2020 | 0 USD | 47.55 M USD | 12.3 M USD | 0 USD | 0 USD | 22.86 M USD | 4.62 M USD | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD | 91,000 USD | 0 USD | 0 USD |
| 2021 | 220 M USD | 0 USD | 22.36 M USD | 0 USD | 0 USD | 0 USD | 6.7 M USD | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD | 184,000 USD | 0 USD | 587,000 USD |
| 2022 | 0 USD | 0 USD | 0 USD | 45.29 M USD | 0 USD | 0 USD | 0 USD | 10.51 M USD | 9.54 M USD | 5 M USD | 0 USD | 0 USD | 0 USD | 762,000 USD | 0 USD |
3 years
5 years
Max
Details
Revenue by Segment
ⓘOverview of Revenue by Segment
The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.
Interpretation and Use
The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.
Investment Strategy
An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.
Agenus Revenue by Segment
| Segmente | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| License and collaboration milestones | - | - | - | - | 14 M USD |
| Recognition of deferred revenue | - | - | - | - | 1.33 M USD |
| Research and development manufacturing services | - | 291,000 USD | - | - | - |
| Research and Development Manufacturing Services | 106,000 USD | - | - | - | - |
| License and collaboration milestones | Recognition of deferred revenue | Research and development manufacturing services | Research and Development Manufacturing Services | |
|---|---|---|---|---|
| 2018 | 14 M USD | 1.33 M USD | 0 USD | 0 USD |
| 2019 | 0 USD | 0 USD | 0 USD | 0 USD |
| 2020 | 0 USD | 0 USD | 0 USD | 0 USD |
| 2021 | 0 USD | 0 USD | 291,000 USD | 0 USD |
| 2022 | 0 USD | 0 USD | 0 USD | 106,000 USD |
Agenus Revenue by Region US00847G8042 · A1JLKZ
3 years
5 years
10 years
25 Years
Max
Details
Revenue by Segment
ⓘOverview of Revenue by Region
The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.
Interpretation and Usage
The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.
Investment Strategy
An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.
Agenus Revenue by Segment
| Date | Europe | Rest of World | Rest of world member | United States |
|---|---|---|---|---|
| 2022 | - | 10.51 M USD | - | 87.51 M USD |
| 2021 | - | 6.7 M USD | 6.7 M USD | 288.96 M USD |
| 2020 | - | 4.62 M USD | 4.62 M USD | 83.55 M USD |
| 2019 | 690,000 USD | - | - | 149.36 M USD |
| 2018 | 4 M USD | - | - | 32.78 M USD |
| 2017 | 3.99 M USD | - | - | 38.88 M USD |
| 2016 | 2.24 M USD | - | - | 20.33 M USD |
| 2014 | - | - | - | 3.66 M USD |
| Europe | Rest of World | Rest of world member | United States | |
|---|---|---|---|---|
| 2014 | 0 USD | 0 USD | 0 USD | 3.66 M USD |
| 2016 | 2.24 M USD | 0 USD | 0 USD | 20.33 M USD |
| 2017 | 3.99 M USD | 0 USD | 0 USD | 38.88 M USD |
| 2018 | 4 M USD | 0 USD | 0 USD | 32.78 M USD |
| 2019 | 690,000 USD | 0 USD | 0 USD | 149.36 M USD |
| 2020 | 0 USD | 4.62 M USD | 4.62 M USD | 83.55 M USD |
| 2021 | 0 USD | 6.7 M USD | 6.7 M USD | 288.96 M USD |
| 2022 | 0 USD | 10.51 M USD | 0 USD | 87.51 M USD |
Agenus Eulerpool Fair Value
Details
Fair Value
ⓘUnderstanding Fair Value
The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.
Income-Based Fair Value
This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.
Example 2022
Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)
Revenue-Based Fair Value
It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.
Example 2022
Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)
Dividend-Based Fair Value
This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.
Example 2022
Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)
Expectations and Forecasts
Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.
Comparative Analysis
Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.
Agenus historical P/E ratio, EBIT multiple, and P/S ratio
Agenus shares outstanding US00847G8042 · A1JLKZ
The number of shares was Agenus in 2024 — This indicates how many shares 17.894 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Agenus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Agenus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Agenus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Agenus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 372,000 Aktien |
| 2005 | 380,000 Aktien |
| 2006 | 382,000 Aktien |
| 2007 | 388,000 Aktien |
| 2008 | 527,000 Aktien |
| 2009 | 658,000 Aktien |
| 2010 | 805,000 Aktien |
| 2011 | 995,000 Aktien |
| 2012 | 1.18 M Aktien |
| 2013 | 1.49 M Aktien |
| 2014 | 2.99 M Aktien |
| 2015 | 3.91 M Aktien |
| 2016 | 4.35 M Aktien |
| 2017 | 4.92 M Aktien |
| 2018 | 5.54 M Aktien |
| 2019 | 6.75 M Aktien |
| 2020 | 8.63 M Aktien |
| 2021 | 11.45 M Aktien |
| 2022 | 14.09 M Aktien |
| 2023 | 17.89 M Aktien |
| 2024e | 17.89 M Aktien |
| 2025e | 17.89 M Aktien |
| 2026e | 17.89 M Aktien |
| 2027e | 17.89 M Aktien |
| 2028e | 17.89 M Aktien |
| 2029e | 17.89 M Aktien |
| 2030e | 17.89 M Aktien |
Agenus stock splits
In Agenus's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Agenus.
Agenus latest earnings and earnings surprises
| Date | EPS Estimate | EPS Actual | Quarterly report |
|---|---|---|---|
| 9/30/2024 | -2.38 | -3.08 (-29.49 %) | 2024 Q3 |
| 6/30/2024 | -1.47 | -2.52 (-71.27 %) | 2024 Q2 |
| 3/31/2024 | -3.28 | -3.04 (7.33 %) | 2024 Q1 |
| 12/31/2023 | -1.07 | -2.6 (-142.76 %) | 2023 Q4 |
| 9/30/2023 | -3.92 | -3.2 (18.3 %) | 2023 Q3 |
| 6/30/2023 | -4.05 | -4 (1.13 %) | 2023 Q2 |
| 3/31/2023 | -4.28 | -4.4 (-2.71 %) | 2023 Q1 |
| 12/31/2022 | -4.45 | -4.8 (-7.77 %) | 2022 Q4 |
| 9/30/2022 | -3.83 | -3.8 (0.65 %) | 2022 Q3 |
| 6/30/2022 | -4.69 | -3.4 (27.54 %) | 2022 Q2 |
1
2
3
4
5
...
10
Eulerpool ESG Scorecard© for the Agenus stock
Eulerpool World ESG Rating (EESG©)
43/ 100
🌱 Environment
19
👫 Social
83
🏛️ Governance
28
Environment
Scope 1 - Direct Emissions | |
Scope 2 - Indirect emissions from purchased energy | |
Scope 3 - Indirect emissions within the value chain | |
Total CO₂ emissions | |
| CO₂ reduction strategy | |
| Coal energy | |
| Nuclear power | |
| Animal experiments | |
| Fur & Leather | |
| Pesticides | |
| Palm Oil | |
| Tobacco | |
| Genetically modified organisms | |
| Climate concept | |
| Sustainable forestry | |
| Recycling regulations | |
| Environmentally friendly packaging | |
| Hazardous substances | |
| Fuel consumption and efficiency | |
| Water consumption and efficiency |
Social
| Percentage of female employees | |
| Percentage of women in management | |
| Percentage of Asian employees | |
| Share of Asian management | |
| Percentage of Hispanic/Latino employees | |
| Hispano/Latino Management share | |
| Percentage of Black employees | |
| Black Management Share | |
| Percentage of white employees | |
| White Management Share | |
| Adult content | |
| Alcohol | |
| Weapons | |
| Firearms | |
| Gambling | |
| Military contracts | |
| Human rights concept | |
| Privacy concept | |
| Occupational health and safety | |
| Catholic |
Governance (Corporate Governance)
| Environmental reporting | |
| Stakeholder Engagement | |
| Call Back Policies | |
| Antitrust law |
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Agenus shareholders
% | Name | Stocks | Change | Date |
|---|---|---|---|---|
| 9.18480 % | The Vanguard Group, Inc. | 2,154,754 | 4,897 | 6/30/2024 |
| 5.98896 % | BlackRock Institutional Trust Company, N.A. | 1,405,009 | 79,260 | 6/30/2024 |
| 3.30350 % | Invus Public Equities Advisors, LLC | 775,000 | -6,562 | 6/30/2024 |
| 1.95243 % | State Street Global Advisors (US) | 458,040 | 85,422 | 6/30/2024 |
| 1.92260 % | Geode Capital Management, L.L.C. | 451,043 | 46,062 | 6/30/2024 |
| 1.64130 % | Morgan Stanley & Co. LLC | 385,048 | 278,090 | 6/30/2024 |
| 1.33572 % | Deep Track Capital LP | 313,359 | -1,271,518 | 6/30/2024 |
| 1.11125 % | Point72 Asset Management, L.P. | 260,700 | -1,244,986 | 6/30/2024 |
| 1.08410 % | Renaissance Technologies LLC | 254,329 | -16,457 | 6/30/2024 |
| 1.01540 % | Invesco Capital Management LLC | 238,213 | 234,927 | 6/30/2024 |
1
2
3
4
5
...
10
Agenus Executives and Management Board
Dr. Garo Armen
(70)Agenus Chairman of the Board, Chief Executive Officer, Co-Founder (since 1994)
Compensation 5.63 M
Dr. Steven O'Day
(61)Agenus Chief Medical Officer
Compensation 1.31 M
Ms. Christine Klaskin
(57)Agenus Vice President - Finance
Compensation 628,125
Mr. Brian Corvese
(65)Agenus Independent Director
Compensation 589,503
Mr. Timothy Wright
(65)Agenus Lead Independent Director
Compensation 367,500
1
2
3
Agenus Supply Chain
| Name | Relationship | Two-week correlation | One-month correlation | Three-Month Correlation | Six-Month Correlation | One Year Correlation | Two-Year Correlation |
|---|---|---|---|---|---|---|---|
| SupplierCustomer | 0,43 | 0,90 | 0,65 | 0,77 | 0,72 | ||
| SupplierCustomer | 0,38 | 0,76 | 0,78 | 0,74 | 0,90 | 0,43 | |
| SupplierCustomer | 0,19 | 0,59 | -0,03 | -0,32 | 0,08 | 0,02 | |
| SupplierCustomer | 0,09 | -0,37 | -0,79 | -0,80 | -0,41 | -0,32 | |
| SupplierCustomer | 0,08 | 0,57 | -0,84 | -0,75 | -0,87 | -0,42 | |
| SupplierCustomer | -0,06 | -0,73 | 0,90 | 0,82 | 0,80 | 0,38 | |
 Targovax | SupplierCustomer | -0,09 | 0,83 | 0,32 | 0,66 | 0,92 | 0,49 |
| SupplierCustomer | -0,17 | -0,58 | -0,33 | 0,38 | 0,57 | 0,31 | |
| SupplierCustomer | -0,18 | 0,10 | -0,38 | 0,52 | 0,57 | 0,38 | |
| SupplierCustomer | -0,45 | -0,64 | -0,93 | -0,84 | -0,54 | -0,31 |
1
Most common questions regarding Agenus
What is the P/S ratio of Agenus 2025?
The Agenus P/S ratio is 0.42.
What is the Quality Investing of Agenus?
The Quality Investing for Agenus is 6/10.
What is the revenue of Agenus 2025?
The expected Agenus revenue is 150.15 M USD.
How high is the profit of Agenus 2025?
The expected Agenus profit is -172.1 M USD.
What is the business model of Agenus
No history available for Agenus.
What is the Agenus dividend?
Agenus pays a dividend of 0 USD distributed over payouts per year.
How often does Agenus pay dividends?
The dividend cannot currently be calculated for Agenus or the company does not pay out a dividend.
What is the Agenus ISIN?
The ISIN of Agenus is US00847G8042.
What is the Agenus WKN?
The WKN of Agenus is A1JLKZ.
What is the Agenus ticker?
The ticker of Agenus is AGEN.
How much dividend does Agenus pay?
Over the past 12 months, Agenus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Agenus is expected to pay a dividend of 0 USD.
What is the dividend yield of Agenus?
The current dividend yield of Agenus is .
When does Agenus pay dividends?
Agenus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Agenus?
Agenus paid dividends every year for the past 0 years.
What is the dividend of Agenus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Agenus located?
Agenus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Agenus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Agenus from 1/31/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/31/2025.
When did Agenus pay the last dividend?
The last dividend was paid out on 1/31/2025.
What was the dividend of Agenus in the year 2024?
In the year 2024, Agenus distributed 0 USD as dividends.
In which currency does Agenus pay out the dividend?
The dividends of Agenus are distributed in USD.
Agenus stock
Sector
Health
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website Agenus
Country
United States of America 🇺🇸
Currency
USD
Initial public offering
Feb 4, 2000
GOSIN
Global Open Securities Identification Number
Cusip
00847G705
Sedol
B58J3K4
Market capitalization
Quality Investing
6 / 10Details
PEG
0.01
P/E ratio
Forward P/E ratio
-0.29
P/S ratio
Forward P/S ratio
0.48
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
Agenus Eulerpool News
Agenus News
Agenus Ticker
| Stock Exchange | Agenus Ticker |
|---|---|
| DÜSSELDORF | AJ81.DU |
| FRANKFURT | AJ81.F |
| MUNICH | AJ81.MU |
| NASDAQ | AGEN |
| SIX | AJ81.SW |
All fundamentals about Agenus
Our stock analysis for Agenus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Agenus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
